Literature DB >> 23312788

Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.

Masafumi Koga1, Jun Murai, Shinya Morita, Hiroshi Saito, Soji Kasayama.   

Abstract

OBJECTIVE: It has been suggested that plasma glucose (PG) levels per se and long-term variations in PG levels are associated with diabetic vascular complications. Glycated albumin (GA) reflects shorter-term glycemic control, as well as postprandial PG levels, as compared to HbA1c. In this study, we hypothesized that GA more strongly reflects long-term variations in PG levels than HbA1c, and compared the variability of HbA1c and that of GA in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
METHODS: This study included 8 T1DM patients and 48 T2DM patients. Over a 1-year period, HbA1c and GA were measured every month and the mean values and coefficients of variation (CV) for each patient were calculated.
RESULTS: In both T1DM and T2DM patients, the CV of GA was significantly higher than the CV of HbA1c. Both the CV of HbA1c and the CV of GA were significantly higher in the T1DM patients than in the T2DM patients.
CONCLUSION: The annual variability in GA was greater than that in HbA1c. In addition, the annual variability in HbA1c and that in GA in the T1DM patients were greater than in the T2DM patients. Our findings suggest that GA more accurately reflects long-term variations in PG levels than HbA1c.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312788     DOI: 10.1016/j.jdiacomp.2012.12.001

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  12 in total

1.  Morbidity and readmission after open reduction and internal fixation of ankle fractures are associated with preoperative patient characteristics.

Authors:  Bryce A Basques; Christopher P Miller; Nicholas S Golinvaux; Daniel D Bohl; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2014-10-22       Impact factor: 4.176

Review 2.  Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Authors:  Elisa Danese; Martina Montagnana; Antonio Nouvenne; Giuseppe Lippi
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

Review 3.  Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.

Authors:  Ji-Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

Review 4.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 5.  Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity.

Authors:  Xiaoting Luo; Jinzi Wu; Siqun Jing; Liang-Jun Yan
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

6.  Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetes.

Authors:  Yong-ho Lee; Mi Hyang Kown; Kwang Joon Kim; Eun Young Lee; Daham Kim; Byung-Wan Lee; Eun Seok Kang; Bong Soo Cha; Hyun Chul Lee
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 7.  Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.

Authors:  Liang-Jun Yan
Journal:  J Diabetes Res       Date:  2014-06-16       Impact factor: 4.011

8.  Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes.

Authors:  Dana Mihaela Ciobanu; Florina Bogdan; Cristina-Ioana Pătruţ; Gabriela Roman
Journal:  Med Pharm Rep       Date:  2019-04-25

9.  Cyclical variation in HbA1c values during the year: clinical and research implications.

Authors:  Nathan R Hill; Catherine J Peters; Rebecca J Thompson; David R Matthews; Peter C Hindmarsh
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

10.  Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.

Authors:  Ji Eun Jun; Seung-Eun Lee; You-Bin Lee; Ji Yeon Ahn; Gyuri Kim; Sang-Man Jin; Kyu Yeon Hur; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Cardiovasc Diabetol       Date:  2017-10-10       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.